Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Department of Medicine and Health

Faculty of Health Sciences

University of Linkoping

Sweden

Name/email consistency: high

Department of Medicine and Health, Faculty of Health Sciences, University of Linkoping, Sweden. 2004 - 2009
Faculty of Health Sciences, Linköping University, Bromma, Sweden. 2007 - 2009
Faculty of Health Sciences, Linköping University; and Stockholm Heart Center, Bergviksvägen 48, SE-167 63 Bromma, Sweden. 2008

Is high HDL cholesterol always good? Olsson, A.G. Ann. Med. (2009) [Pubmed]
Lipid lowering and aortic valve disease. Olsson, A.G. Curr. Atheroscler. Rep (2009) [Pubmed]
Will CETP inhibition survive the demise of torcetrapib? Olsson, A.G. Curr. Atheroscler. Rep (2008) [Pubmed]
Effects of high-dose atorvastatin in patients > or =65 years of age with acute coronary syndrome (from the myocardial ischemia reduction with aggressive cholesterol lowering [MIRACL] study). Olsson, A.G., Schwartz, G.G., Szarek, M., Luo, D., Jamieson, M.J. Am. J. Cardiol. (2007) [Pubmed]
Are lower levels of low-density lipoprotein cholesterol beneficial? a review of recent data. Olsson, A.G. Curr. Atheroscler. Rep (2006) [Pubmed]
Expanding options with a wider range of rosuvastatin doses. Olsson, A.G. Clin. Ther (2006) [Pubmed]
High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial. Olsson, A.G., Schwartz, G.G., Szarek, M., Sasiela, W.J., Ezekowitz, M.D., Ganz, P., Oliver, M.F., Waters, D., Zeiher, A. Eur. Heart J. (2005) [Pubmed]
Psychosocial factors and coronary heart disease. Olsson, A.G. Curr. Atheroscler. Rep (2004) [Pubmed]